Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Wyeth |
---|---|
Information provided by: | Wyeth |
ClinicalTrials.gov Identifier: | NCT00427258 |
Absorption, distribution, metabolism, and excretion (ADME) study with 14C in healthy young men.
Condition | Intervention | Phase |
---|---|---|
Healthy |
Drug: MOA-728 |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Pharmacokinetics Study |
Official Title: | An Open-Label, Single-Dose Study of the Mass Balance and Metabolic Disposition of Orally Administered [14C]MOA-728 in Healthy Men |
Ages Eligible for Study: | 18 Years to 50 Years |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Contact: Trial Manager | clintrialparticipation@wyeth.com |
Study Director: | Medical Monitor | Wyeth |
Study ID Numbers: | 3200A3-1106 |
Study First Received: | January 25, 2007 |
Last Updated: | January 26, 2007 |
ClinicalTrials.gov Identifier: | NCT00427258 |
Health Authority: | United States: Food and Drug Administration |
healthy subjects |
Healthy |